Related Experiment Videos
Hepatitis B vaccination in uremic patients: comparison between recombinant and plasma-derived vaccine
R Bergia1, M Pellerey, I Berto
1Servizio di Nefrologia e Dialisi, Ospedale degli Infermi, Biella, Italy.
Nephron
|January 1, 1992
Abstract:
The immune response to recombinant and plasma-derived vaccines was evaluated in 53 and 43 uremic patients, respectively. The total rate of seroconversion was around 80% with both vaccines, although a significantly higher response was obtained with the protocol using recombinant vaccine.